INCR
InterCure Ltd.
5.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -24.1% | -7.1% | -18.5% | -40.3% | -33.6% | -120.9% | – | – | – | -45.0% | 12.0% | 11.4% | 13.2% | -15.1% | -28.0% | 6.2% | |
| 3.8% | 1.9% | 1.3% | 1.7% | 0.4% | – | – | – | – | 0.3% | 5.0% | 3.4% | 3.0% | 3.7% | 6.4% | 6.3% | |
| 1.6% | -5.3% | 8.5% | -2.6% | – | 23.4% | – | – | – | 727.2% | 15.4% | 2.9% | 2.3% | 0.7% | 1.0% | 0.9% | |
| – | – | – | – | – | – | – | – | – | -100.2% | 70.6% | 6.6% | – | – | – | – | |
| 10.5% | 10.6% | -4.1% | -14.7% | 4.9% | -27.0% | – | – | – | -7.5% | -6.3% | -0.8% | -0.8% | -12.2% | -3.8% | 7.0% | |
| 0.0% | 0.1% | 3.5% | 3.2% | 0.0% | 0.0% | – | – | – | 0.0% | 32.0% | 6.4% | 5.1% | 0.7% | 1.8% | 1.3% | |
| 3.8% | 2.7% | -3.1% | 8.8% | 15.9% | -667.6% | – | – | – | -431.8% | -35.0% | -29.7% | -36.7% | 1.3% | 7.4% | -0.7% | |
| – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | – | – | – | – | – | – | – | – | -5.7% | -20.9% | 30.0% | 35.4% | -17.4% | 3.2% | -10.8% | |
| 13.4% | 6.3% | 50.7% | – | 6.2% | 943.5% | – | – | – | 741.3% | 38.9% | 90.1% | 31.0% | -23.3% | 11.1% | -17.3% | |
| -6.9% | 1.9% | 29.1% | -31.5% | -11.5% | 178.3% | – | – | – | 246.0% | 16.2% | 72.1% | 9.4% | -37.0% | -9.6% | -11.8% | |
| -24.1% | -7.3% | -22.0% | -43.5% | -33.6% | -120.9% | – | – | – | -45.0% | -20.0% | 5.0% | 8.1% | -15.8% | -29.9% | 4.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.